$BRTX Balance Sheet | Understand Stock

$BRTX

$1.36 -$0.22 (13.92%) Close

$BRTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021
Assets
Current Assets:
Cash
Cash and cash equivalents
Investments held in marketable securities
Accounts receivable
Prepaid expenses
Prepaid expenses and other current assets
Deferred offering costs
Total Current Assets

Deferred offering costs
Property and equipment, net
Right-of-use assets
Intangible assets, net
Total Assets
Liabilities and Stockholders’ Equity
Current Liabilities:
Accounts payable
Accrued interest
Lease liability
PPP loan payable, current portion
Accrued expenses and other current liabilities
Deferred revenue
Warrant liabilities
Total Current Liabilities

Lease liability, net of current portion
Notes payable, net of debt discount of $- and $5,366,869, respectively
PPP loan payable, net of current portion
Total Liabilities
Stockholders’ Equity:
Preferred stock, $0.01 par value; 20,000,000 shares authorized; Series B Convertible Preferred Stock; 1,543,158 shares designated, 0 and 1,398,158 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively
Series A Convertible Preferred Stock
Series B Convertible Preferred Stock
Total preferred stock, $0.01 par value; 20,000,000 shares authorized; Series B Convertible Preferred Stock; 1,543,158 shares designated, 0 and 1,398,158 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively

Common stock, $0.0001 par value; 75,000,000 shares authorized; 25,478,170 and 8,876,242 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Total Stockholders’ Equity
Total Liabilities and Stockholders’ Equity

Comments